Startup profile · funding coverage
Incision funding, valuation and investors
Amsterdam hospital software provider helping operating-room and sterile-processing teams prepare for procedures.
Verified company research · funding, investors and latest developments
Keep track of Incision
Save this profile to your VCT watchlist for a quick return.
Funding, valuation & investors
Answer-first snapshotLatest funding
Not publicly disclosed
Latest known valuation
Not publicly disclosed
Total disclosed equity funding
Not publicly disclosed
Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.
Current status
private
Stage not recorded · Amsterdam, Netherlands
Overview
Incision Group B.V., founded in Amsterdam in 2014 by Prof. Dr. Theo Wiggers, offers Incision Assist for surgeon-specific setup and preference cards, MySPD for sterile processing education and competency tracking, and Academy for accredited surgical education. Hospitals purchase and configure Assist; it is not a consumer app.
The manager says the software reaches professionals in approximately 300 hospitals across 20+ countries, while performance improvements are selected reported hospital cases, not controlled causal estimates. HERAN HealthTech Fund II announced a €4M investment on November 10, 2026 without a disclosed funding stage or valuation. https://www.heranpartners.com/news-insights/incision-investment ; https://www.incision.care/products/assist
Why Incision is interesting
HERAN HealthTech Fund II announced a €4M investment on November 10, 2026 for U.S. expansion; the announcement does not assign it a Series A/B stage. Incision sells a workflow and knowledge platform to hospitals rather than consumer medical advice.
Product & use cases
ILLUSTRATIVE HOSPITAL BUYER WORKFLOW (not hands-on testing): 1) An OR manager commissions a hospital-wide setup; 2) Incision's clinical implementation team imports surgeon preference cards and staff observations; 3) they add relevant instruments, devices, surgeon and procedure-specific photos/videos/3D room arrangements; 4) staff check preparations via web/mobile before surgery; 5) the hospital maintains and updates those local instructions. MySPD covers sterile processing training and skills tracking; Academy provides surgical education. Public license prices are not disclosed. The vendor states the platform does not handle patient-identifiable data and is generally connected one-way to hospital systems.
- Operating-room staff: quick access to a specific surgeon's preparation instructions, instrument trays, room layout and device guidance.
- Sterile processing departments: structured education, onboarding and competency records through MySPD.
- Hospitals with rotating or temporary staff: preserve local procedural knowledge and support standardization; impact figures are vendor-reported case studies.
Key facts
- HERAN GP reports €4M invested November 10, 2026, its Fund II's third investment; no named venture-round stage.
- Investor says about 300 hospitals / 20+ countries use Incision products; not independently audited.
- Case-study outcomes include 15% faster turnovers; selected vendor-reported cases should not be generalized.
Funding history (newest first)
HERAN HealthTech Fund II investment; stage undisclosed
2026-11-10 €4M reported investment; instrument, valuation and other investor allocations undisclosed- HERAN HealthTech Fund II (participant)
Source: Read source · heranpartners.com
Competitive landscape
Edge: Content is customized around hospital/surgeon workflows and supported by clinical implementation specialists. Potential burden is keeping local preference cards and visuals current; procurement, training and workflow change are required.
-
Paper and EHR-stored preference cards incumbent
Often fragmented and less accessible but already embedded in hospital workflows.
-
Hospital learning management systems alternative
Can deliver training but may lack surgeon/procedure-specific point-of-care setup guidance.
-
Caresyntax adjacent
Surgical video/analytics platform; Incision announced a partnership, not simply a direct replacement.
Market / IPO context
Editorial / static context — not a live quote.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.